Piperazine

Piperazine

SCHEMBL699478

C1CNCCN1.NCCO

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.57
▸ TSHR P16473 1/20 0.57
▸ HIF1A Q16665 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ PDE4A P27815 1/20 0.43
▸ KDR P35968 1/20 0.43
▸ CXCR4 P61073 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ GBA1 P04062 4/20 0.31
▸ GAA P10253 2/20 0.31
▸ PYGL P06737 1/20 0.31
▸ GBA2 Q9HCG7 1/20 0.31
▸ GLB1 P16278 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Monoethanolamine SCHEMBL27274629 0.96 — —
Piperidine SCHEMBL676507 0.84 ALDH1A1 (0.53) ALDH1A1TSHRCXCR4SMN1; SMN2
Sulfuric Acid SCHEMBL28872449 0.82 TSHR (0.44) ALDH1A1TSHRKDM4E
Piperazine SCHEMBL2882663 0.81 HIF1A (0.55) ALDH1A1HIF1AMAPTPDE4AKDR
Piperazine SCHEMBL14739784 0.81 HIF1A (0.55) ALDH1A1HIF1AMAPTPDE4AKDR
Piperazine SCHEMBL9877421 0.81 HIF1A (0.55) ALDH1A1TSHRHIF1AMAPTPDE4A
Piperazine SCHEMBL5946683 0.81 HIF1A (0.55) ALDH1A1HIF1AMAPTPDE4AKDR
Morpholine SCHEMBL28011699 0.80 KDM4E (0.55) ALDH1A1TSHRSMN1; SMN2GAAKDM4E
Piperazine SCHEMBL3905641 0.77 HIF1A (0.50) ALDH1A1HIF1AMAPTPDE4AKDR
Ethylenediamine SCHEMBL1030825 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105153064-A Method for synthesizing piperazine and derivatives of piperazine through monoethanolamine gas-solid phase catalysis XIAN MODERN CHEMISTRY RES INST 2015-12-16 — — CN claimed
CN-109890366-A Combination medicine for treating cardiovascular diseases and preparation and use methods thereof 美进医药公司 2019-06-14 — — CN disclosed
EP-3430064-A1 WASHING- AND CLEANING-ACTIVE POLYMER FILMS, PROCESS FOR THE PRODUCTION THEREOF AND USE THEREOF BASF SE (DE) 2019-01-23 — — EP disclosed
CN-104258725-B Use particle capture CO comprising biocatalyzer2method 二氧化碳处理公司 2016-08-24 — — CN disclosed
CN-105153064-A Method for synthesizing piperazine and derivatives of piperazine through monoethanolamine gas-solid phase catalysis XIAN MODERN CHEMISTRY RES INST 2015-12-16 — — CN disclosed
WO-2012025190-A1 ELECTROCHEMICALLY-GATED TRANSISTOR AND A METHOD FOR ITS MANUFACTURE Karlsruher Institut für Technologie (DE) 2012-03-01 — — WO disclosed
EP-2423965-A1 Electrochemically-gated transistor and a method for its manufacture Karlsruher Institut für Technologie (DE) 2012-02-29 — — EP disclosed
WO-2000033654-A1 USE OF PROTEASE INHIBITORS TO MODULATE CELLULAR PATHWAYS, IMMUNITY AND THERAPIES ASSOCIATED THEREWITH UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) 2000-06-15 — — WO disclosed
CN-1045098-A Process for preparing linear chain-extended polyalkylenepolyamines DOW CHEMICAL CO (US) 1990-09-05 — — CN disclosed
Send feedback